How much lowering of blood pressure is required to prevent cardiovascular disease in patients with and without previous cardiovascular disease?
<strong>Purpose of Review<br></strong> To review the recent large-scale randomised evidence on pharmacologic reduction in blood pressure for the primary and secondary prevention of cardiovascular disease. <br><strong> Recent Findings<br></strong> Based on fi...
Main Authors: | Canoy, D, Nazarzadeh, M, Copland, E, Bidel, Z, Rao, S, Li, Y, Rahimi, K |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Springer Nature
2022
|
Similar Items
-
Blood pressure treatment: how low should you go? – Authors' reply
by: Rahimi, K, et al.
Published: (2021) -
Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis
by: Rahimi, K, et al.
Published: (2021) -
Blood pressure-lowering treatment lowers mortality and cardiovascular disease risk, but whether effects differ at an arbitrary threshold of 140 mm Hg systolic blood pressure requires further research
by: Canoy, D, et al.
Published: (2018) -
Systolic blood pressure, chronic obstructive pulmonary disease and cardiovascular risk
by: Rao, S, et al.
Published: (2023) -
Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis
by: Nazarzadeh, M, et al.
Published: (2022)